首页   按字顺浏览 期刊浏览 卷期浏览 Oxygen consumption and central hemodynamics in septic shock treated with antibiotics&co...
Oxygen consumption and central hemodynamics in septic shock treated with antibiotics, fluid infusions, and corticosteroids

 

作者: JOHAN OTTOSSON,   TORE PERSSON,   INGEMAR DAWIDSON,  

 

期刊: Critical Care Medicine  (OVID Available online 1989)
卷期: Volume 17, issue 8  

页码: 772-779

 

ISSN:0090-3493

 

年代: 1989

 

出版商: OVID

 

数据来源: OVID

 

摘要:

The multidimensional pathophysiology of septic shock is poorly understood and treatment modalities are controversial. The present study evaluates the relative importance of three therapeutic measures: antibiotics (trimethoprim and sulphamethovazole [TS]); fluid infusions (lactated Ringer's solution [RL] and 3% albumin [Alb]), and pharmacologic doses of corticosteroids (CS) (dexamethasone [DM]), using central hemodynamics (plasma volume [PV], cardiac output, oxygen consumption [&OV0312;O2]), and survival as end-points.Septic shock was induced by intraperitoneal injection of liveEscherichia colibacteria. At 5 h in untreated septic rats, PV had dropped to 76%, cardiac output to 69%, and &OV0312;O2to 71% of preshock levels. Untreated septic animals had a mean survival time of 9.7 ± 1.7 (SD) h, with none surviving 24 h. Regardless of therapy, cardiac output and &OV0312;O2at 10 h were predictors of survival time (p< .01). Treatment was initiated at 5.5 h after bacterial injection, at a time when TS therapy alone had not improved the 24-h survival rate. Animals treated with DM. RL, and Alb, in this order, exhibited progressively improved central hemodynamics, and 24-h survival rate increased to 60% compared with 0 in untreated animals (p< .001). The combination of DM and RL produced no further improvement. However, DM combined with 3% Alb restored &OV0312;O2cardiac output, and PV to 81%, 100%, and 125%, respectively, increasing the 24-h survival rate to 97% (29/30), significantly greater than that achieved by any other treatment modality (p< .05).

 

点击下载:  PDF (534KB)



返 回